Pfizer is expected to seek FDA emergency use authorization for a coronavirus vaccine booster shot for people 18 and older, a Biden administration official said.
What's the best booster to get? And other questions about Covid-19 boostersThe expected EUA request was first reported by the Washington Post.Authorization would bring the country one step closer to President Joe Biden's mid-August prediction that boosters would be available for all adults in the United States. It also comes as federal health officials have made clear their concern about waning immunity as the nation heads into the winter months.
Pfizer said Monday the company has no update about whether it will seek booster authorization for additional groups.More than 24 million fully vaccinated people, about 12.4% of the total, have already received a booster dose of vaccine.CNN's Amanda Sealy contributed to this report.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
U.S. Opens Borders to Vaccinated Europeans, Others, After More Than 18 MonthsVaccinated non-American citizens from previously restricted countries—predominantly in Europe—are allowed to travel to the U.S. from today, if they have proof of vaccination and a negative Covid-19 test taken within the prior three days.
Les mer »
18 best photos of Lady Louise Windsor to celebrate her milestone birthdayThe Earl and Countess of Wessex celebrates her 18th birthday on Monday 8 November
Les mer »
As Lady Louise Windsor Turns 18, She'll Choose Whether to Become “Princess”Lady Louise Windsor Is Turning 18, But She Probably Won’t Take a “Princess” Title
Les mer »
18 Times Celebrities Called Out The Designers Who Refused To Dress Them'I'm not my body. I'm a whole person.' —Gabourey Sidibe
Les mer »
Un proyecto transfronterizo vacuna a niños de 12 a 18 años de Baja CaliforniaEl programa piloto utiliza vacunas donadas por el condado de San Diego
Les mer »
Pfizer Says Its Covid Pill Reduced Risk Of Hospitalization And Death By 89% In Clinical StudyThe company’s announcement comes one day after Merck’s antiviral Covid pill, Molnupiravir, was authorized for use in the United Kingdom
Les mer »